Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
7/2019 ceased to operate
IonMed
IonMed Overview
IonMed is bringing a plasma-based technology to advanced clinical stages with its BioWeld1 proprietary technology. BioWeld1 is a cold plasma device, complete with dedicated disposable tips and a biological film, that is ideally suited for wound and surgical incision closure and skin-graft fixation, with additional clinical applications in development.
Once the graft is placed on the grafting site, Chitoplast strips are applied along the graft edges and adjacent tissue. Alternatively, the Chitoplast can be applied along the incision edges. Cold plasma is then applied along the Chitoplast strips, which cover the graft edges, causing hemostasis and further adherence of the Chitoplast, leading to a closer approximation of the incision or skin-graft edges. The combined actions of the plaster and plasma provide the basis for the subsequent natural healing process.
IonMed's BioWeld1 is CE cleared for surgical incision closure, and the company is certified to the ISO13845 standard. The system's CE clearance for skin graft fixation application is pending.
IonMed Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 16, 2015
www.israel21c.org
Cold-plasma incision sealer to be used in skin grafts
#Investment #Expand
Oct 20, 2014
www.prnewswire.com
IonMed Receives CE Mark Clearance for Bioweld1™ Cold Plasma System
#Partners
Jun 17, 2013
www.dailymail.co.uk
Could a 'welding torch' banish the caesarean scar? New technique could spell end of staples and stitches
#Customers
Jun 13, 2013
www.israel21c.org
Say goodbye to surgical stitches and staples
#Customers
May 8, 2013
www.prnewswire.co.uk
IonMed(TM) Announces Successful Completion of the First European Cold Plasma Clinical Study for Closure of Surgical Wounds